title: Withdrawal of immunosuppression contributing to the remission of malignant melanoma: a case report.
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA 02115, USA. Stephen_Hodi@DFCI.Harvard.Edu
authors.forename: F Stephen
authors.initials: FS
authors.lastname: Hodi
authors.forename: Scott
authors.initials: S
authors.lastname: Granter
authors.forename: Joseph
authors.initials: J
authors.lastname: Antin
mesh_terms: D000741:Anemia, Aplastic / Q000150:complications / Q000188:drug therapy; D016572:Cyclosporine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D008545:Melanoma / Q000150:complications / Q000276:immunology* / Q000628:therapy; D012074:Remission Induction; D020123:Sirolimus / Q000008:administration & dosage; D016559:Tacrolimus / Q000008:administration & dosage
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D020123:Sirolimus; D016559:Tacrolimus